Skip to main content

Articles

Page 36 of 38

  1. The CyberKnife is an appealing delivery system for hypofractionated stereotactic body radiation therapy (SBRT) because of its ability to deliver highly conformal radiation therapy to moving targets. This confo...

    Authors: Eric K Oermann, Simeng Suy, Heather N Hanscom, Joy S Kim, Sue Lei, Xia Yu, Guowei Zhang, Brook Ennis, JoyAnn P Rohan, Nathaniel Piel, Benjamin A Sherer, Devin Borum, Viola J Chen, Gerald P Batipps, Nicholas L Constantinople, Stephen W Dejter…
    Citation: Journal of Hematology & Oncology 2011 4:12
    Content type: Research Published on:

  2. The objectives of the present study are to investigate the efficacy and safety profile of gemcitabine-based combinations in the treatment of locally advanced and metastatic pancreatic adenocarcinoma (LA/MPC).

    Authors: Jing Hu, Gang Zhao, Hong-Xia Wang, Lei Tang, Ying-Chun Xu, Yue Ma and Feng-Chun Zhang
    Citation: Journal of Hematology & Oncology 2011 4:11
    Content type: Research Published on:

  3. Mast cell activation disease comprises disorders characterized by accumulation of genetically altered mast cells and/or abnormal release of these cells' mediators, affecting functions in potentially every orga...

    Authors: Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
    Citation: Journal of Hematology & Oncology 2011 4:10
    Content type: Review Published on:

  4. Acute leukemia with coexisting Gilbert's syndrome treated by allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rarely reported. Here we described a case whose transaminase levels were almost no...

    Authors: Guo-Pan Yu, Qian-Li Jiang, Zhi-Ping Fan, Jie Zhao, Qi Wei, Jing Sun, Fan-Yi Meng and Qi-Fa Liu
    Citation: Journal of Hematology & Oncology 2011 4:9
    Content type: Letter to the Editor Published on:

  5. The unfolded protein response ( UPR) is a cascade of intracellular stress signaling events in response to an accumulation of unfolded or misfolded proteins in the lumen of the endoplasmic reticulum (ER). Cancer c...

    Authors: Xuemei Li, Kezhong Zhang and Zihai Li
    Citation: Journal of Hematology & Oncology 2011 4:8
    Content type: Review Published on:

  6. BCR-ABL kinase domain (KD) mutation is the major mechanism contributing to suboptimal response to tyrosine kinase inhibitors (TKI) in BCR-ABL-positive chronic myeloid leukemia (CML) patients. T315I mutation, as o...

    Authors: Wanwisa Wongboonma, Wanna Thongnoppakhun and Chirayu U Auewarakul
    Citation: Journal of Hematology & Oncology 2011 4:7
    Content type: Research Published on:

  7. The BCR-ABL1 translocation occurs in chronic myeloid leukemia (CML) and in 25% of cases with acute lymphoblastic leukemia (ALL). The advent of tyrosine kinase inhibitors (TKI) has fundamentally changed the treatm...

    Authors: Hilmar Quentmeier, Sonja Eberth, Julia Romani, Margarete Zaborski and Hans G Drexler
    Citation: Journal of Hematology & Oncology 2011 4:6
    Content type: Research Published on:

  8. Chemotherapy combined concurrently with TKIs produced a negative interaction and failed to improve survival when compared with chemotherapy or TKIs alone in the treatment of non-small cell lung cancer (NSCLC)....

    Authors: Hua Cheng, She-Juan An, Song Dong, Yi-Fang Zhang, Xu-Chao Zhang, Zhi-Hong Chen, Jian-Su and Yi-Long Wu
    Citation: Journal of Hematology & Oncology 2011 4:5
    Content type: Research Published on:

  9. JAK2V617F is found in the majority of patients with Ph- myeloproliferative neoplasms (MPNs) and has become a valuable marker for diagnosis of MPNs. However, it has also been found in many other hematological d...

    Authors: Wanming Zhao, Rufei Gao, Jiyun Lee, Shu Xing, Wanting T Ho, Xueqi Fu, Shibo Li and Zhizhuang J Zhao
    Citation: Journal of Hematology & Oncology 2011 4:4
    Content type: Short report Published on:

  10. This phase I, randomized, multicenter, open-label study investigated the pharmacokinetics, safety, and efficacy of the oral mammalian target of rapamycin inhibitor everolimus in Chinese patients with advanced ...

    Authors: BingHe Xu, YiLong Wu, Lin Shen, DingWei Ye, Annette Jappe, Azzeddine Cherfi, Hui Wang and RuiRong Yuan
    Citation: Journal of Hematology & Oncology 2011 4:3
    Content type: Research Published on:

  11. Our previous study had amplified antigen-specific full-length TCR α and β genes of clonally expanded T cells in the peripheral blood (PB) of patients with diffuse large B-cell lymphoma (DLBCL). The transfer of...

    Authors: Qingsong Yin, Xianfeng Zha, Lijian Yang, Shaohua Chen, Yubing Zhou, Xiuli Wu and Yangqiu Li
    Citation: Journal of Hematology & Oncology 2011 4:2
    Content type: Research Published on:

  12. Myelodysplastic syndrome with isolated chromosome 5q deletion (5q- syndrome) is a clonal stem cell disorder characterized by ineffective hematopoiesis. MicroRNAs (miRNAs) are important regulators of hematopoie...

    Authors: Hana Votavova, Martina Grmanova, Michaela Dostalova Merkerova, Monika Belickova, Alzbeta Vasikova, Radana Neuwirtova and Jaroslav Cermak
    Citation: Journal of Hematology & Oncology 2011 4:1
    Content type: Short report Published on:

  13. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for severe aplastic anemia (SAA). However, graft failure and graft-versus-host disease (GVHD) are major causes of the ea...

    Authors: Sun Zi-Min, Liu Hui-Lan, Geng Liang-Quan, Wang Xin-Bing, Yao Wen, Liu Xin, Ding Kai-Yang, Han Yong-Sheng, Yang Hui-Zhi, Tang Bo-lin, Tong Juan, Zhu Wei-Bo and Wang Zu-Yi
    Citation: Journal of Hematology & Oncology 2010 3:51
    Content type: Letter to the Editor Published on:

  14. Zearalenone (ZEA) is a phytoestrogen from Fusarium species. The aims of the study was to identify mode of human leukemic cell death induced by ZEA and the mechanisms involved.

    Authors: Ratana Banjerdpongchai, Prachya Kongtawelert, Orawan Khantamat, Chantragan Srisomsap, Daranee Chokchaichamnankit, Pantipa Subhasitanont and Jisnuson Svasti
    Citation: Journal of Hematology & Oncology 2010 3:50
    Content type: Research Published on:

  15. We previously reported that allanxanthone C and macluraxanthone, two xanthones purified from Guttiferae trees, display in vitro antiproliferative and proapoptotic activities in leukemic cells from chronic lymphoc...

    Authors: Séverine Loisel, Karine Le Ster, Michèle Meyer, Christian Berthou, Pierre Youinou, Jean-Pierre Kolb and Christian Billard
    Citation: Journal of Hematology & Oncology 2010 3:49
    Content type: Letter to the Editor Published on:

  16. We have previously demonstrated that phenylhexyl isothiocyanate (PHI), a synthetic isothiocyanate, inhibits histone deacetylases and remodels chromatins to induce growth arrest in HL-60 myeloid leukemia cells ...

    Authors: Shaohong Jiang, Xudong Ma, Yiqun Huang, Yunlu Xu, Ruiji Zheng and Jen-Wei Chiao
    Citation: Journal of Hematology & Oncology 2010 3:48
    Content type: Research Published on:

  18. Recent reports indicate that microRNAs (miRNAs) play a critical role in malignancies. However, the role that miRNAs play in pancreatic cancer remains to be determined. The purpose of this study was to investig...

    Authors: Xing J Zhang, Hua Ye, Cheng W Zeng, Bo He, Hua Zhang and Yue Q Chen
    Citation: Journal of Hematology & Oncology 2010 3:46
    Content type: Research Published on:

  19. Discovery of new treatments for lymphoma that prolong survival and are less toxic than currently available agents represents an urgent unmet need. We now have a better understanding of the molecular pathogenes...

    Authors: Patrick B Johnston, RuiRong Yuan, Franco Cavalli and Thomas E Witzig
    Citation: Journal of Hematology & Oncology 2010 3:45
    Content type: Review Published on:

  20. In a human T-cell acute lymphoblastic leukemia (T-ALL) cell line (Molt-4), siRNA-mediated suppression of BCL11B expression was shown to inhibit proliferation and induce apoptosis, functions which may be related t...

    Authors: Xin Huang, Shaohua Chen, Qi Shen, Lijian Yang, Bo Li, Liye Zhong, Suxia Geng, Xin Du and Yangqiu Li
    Citation: Journal of Hematology & Oncology 2010 3:44
    Content type: Research Published on:

  21. Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and cl...

    Authors: Qiong Wu, Shu-Kui Qin, Feng-Meng Teng, Chang-Jie Chen and Rui Wang
    Citation: Journal of Hematology & Oncology 2010 3:43
    Content type: Research Published on:

  22. Breast cancer is a heterogeneous disease composed of different subtypes, characterized by their different clinicopathological characteristics, prognoses and responses to treatment. In the past decade, signific...

    Authors: Rafael Santana-Davila and Edith A Perez
    Citation: Journal of Hematology & Oncology 2010 3:42
    Content type: Review Published on:

  23. Mutations in the nucleophosmin (NPM1) gene have been solely associated with childhood acute myeloid leukemia (AML). We evaluated the frequency of NPM1 mutations in childhood AML, their relation to clinical and cy...

    Authors: Maria Braoudaki, Chrissa Papathanassiou, Katerina Katsibardi, Natalia Tourkadoni, Kalliopi Karamolegou and Fotini Tzortzatou-Stathopoulou
    Citation: Journal of Hematology & Oncology 2010 3:41
    Content type: Research Published on:

  24. Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of anti-cancer drugs in both solid and hematologic malignancies. The HSP90 family includes the cytosolic HSP90 (HSP90AA1), the ER para...

    Authors: Saad Z Usmani, Robert D Bona, Gabriela Chiosis and Zihai Li
    Citation: Journal of Hematology & Oncology 2010 3:40
    Content type: Research Published on:

  25. To report clinical efficacy and toxicity of fractionated CyberKnife radiosurgery for the treatment of hilar lung tumors.

    Authors: Keith Unger, Andrew Ju, Eric Oermann, Simeng Suy, Xia Yu, Saloomeh Vahdat, Deepa Subramaniam, K William Harter, Sean P Collins, Anatoly Dritschilo, Eric Anderson and Brian T Collins
    Citation: Journal of Hematology & Oncology 2010 3:39
    Content type: Short report Published on:

  26. Waldenstrom's Macroglobulinemia is a low-grade B-cell lymphoma characterized by the presence of lymphoplasmacytic cells in the bone marrow and a monoclonal immunoglobulin M in the circulation. Recent evidences...

    Authors: Antonio Sacco, Ghayas C Issa, Yong Zhang, Yang Liu, Patricia Maiso, Irene M Ghobrial and Aldo M Roccaro
    Citation: Journal of Hematology & Oncology 2010 3:38
    Content type: Review Published on:

  27. MicroRNAs are small noncoding RNAs that function to control gene expression. These small RNAs have been shown to contribute to the control of cell growth, differentiation and apoptosis, important features rela...

    Authors: Anuradha Budhu, Junfang Ji and Xin W Wang
    Citation: Journal of Hematology & Oncology 2010 3:37
    Content type: Review Published on:

  28. Optimal conditioning therapy for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains undefined. We retrospectively compared outcomes of a consecutive series of 51 AML patients ...

    Authors: Joseph Pidala, Jongphil Kim, Claudio Anasetti, Mohamed A Kharfan-Dabaja, Taiga Nishihori, Teresa Field, Janelle Perkins, Lia Perez and Hugo F Fernandez
    Citation: Journal of Hematology & Oncology 2010 3:36
    Content type: Research Published on:

  30. Mantle cell lymphoma is a lymphoid entity characterized by adenopathy, blood and bone marrow involment which only recurrent mucosal localisation is the lymphomatoid polyposis. Few other mucosal infiltrations h...

    Authors: Jean-Christophe Ianotto, Adrian Tempescul, Jean-Richard Eveillard, Norbert André, Frederic Morel, Isabelle Quintin-Roué and Christian Berthou
    Citation: Journal of Hematology & Oncology 2010 3:34
    Content type: Letter to the Editor Published on:

  31. Wnt canonical signaling pathway plays a diverse role in embryonic development and maintenance of organs and tissues in adults. It has been observed that Wnt/β-catenin signaling pathway is involved in the patho...

    Authors: Xueling GE and Xin Wang
    Citation: Journal of Hematology & Oncology 2010 3:33
    Content type: Review Published on:

  32. We describe a case of multiple myeloma (MM) and secondary plasma cell leukemia (PCL) secreting IgE-kappa immunoglobulin. To our knowledge, only 2 cases of IgE-producing secondary PCL have been reported in the ...

    Authors: Giampaolo Talamo, William Castellani and Nathan G Dolloff
    Citation: Journal of Hematology & Oncology 2010 3:32
    Content type: Case report Published on:

  33. We report a 49-year-old Chinese male with locally advanced gastric adenocarcinoma achieving pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen. He underwent esoph...

    Authors: Jun Wang, George W Saukel, Carlos A Garberoglio, Wichit Srikureja and Chung-Tsen Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:31
    Content type: Case report Published on:

  34. Mantle cell lymphoma (MCL) is a rare and aggressive type of B-cell non-Hodgkin's lymphoma. Patients become progressively refractory to conventional chemotherapy, and their prognosis is poor. However, a 38% rem...

    Authors: Li Wang, Wen-Yu Shi, Zhi-Yuan Wu, Mariana Varna, Ai-Hua Wang, Li Zhou, Li Chen, Zhi-Xiang Shen, He Lu, Wei-Li Zhao and Anne Janin
    Citation: Journal of Hematology & Oncology 2010 3:30
    Content type: Case report Published on:

  35. The Gγ-158(C→T) polymorphism plays important function in the clinical variability of HbE/β-thalassemia. There is little known about Gγ-158(C→T) polymorphism in HbE/β-thalassemia major in Southern China. This stud...

    Authors: Rong Rong Liu, Ming Yue Wang and Yong Rong Lai
    Citation: Journal of Hematology & Oncology 2010 3:29
    Content type: Letter to the Editor Published on:

  36. Acute promyelocytic leukemia (APL) is a blood cancer that affects people of all ages and strikes about 1,500 patients in the United States each year. The standard treatment of APL has been based on the combine...

    Authors: Clement Yedjou, Paul Tchounwou, John Jenkins and Robert McMurray
    Citation: Journal of Hematology & Oncology 2010 3:28
    Content type: Research Published on:

  37. In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented. The aim of thi...

    Authors: Matthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, Eva Culakova and Gary H Lyman
    Citation: Journal of Hematology & Oncology 2010 3:27
    Content type: Short report Published on:

  38. Prostate cancer remains a significant public health problem, with limited therapeutic options in the setting of castrate-resistant metastatic disease. Angiogenesis inhibition is a relatively novel antineoplast...

    Authors: Clara Hwang and Elisabeth I Heath
    Citation: Journal of Hematology & Oncology 2010 3:26
    Content type: Review Published on:

  39. The ring chromosome is a circular, structural abnormality composed of either multiple chromosomes or a single chromosome with loss of genetic material at one or both ends. This chromosomal rearrangement is oft...

    Authors: Shanthi Sivendran, Stephen Gruenstein, Adriana K Malone and Vesna Najfeld
    Citation: Journal of Hematology & Oncology 2010 3:25
    Content type: Case report Published on:

  40. We report a case of a 48-year-old Chinese female with end-stage renal disease and chronic anemia on hemodialysis. Clonazepam was prescribed for myoclonus disorder two weeks prior to her hospitalization. Subseq...

    Authors: Marnelli A Bautista-Quach, Yu-Min Liao and Chung-Tsen Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:24
    Content type: Case report Published on:

  41. Management of localized primary gastric B lymphoma (PGL) remains controversial. The aim of this study is to compare two treatments: chemotherapy alone and surgery plus chemotherapy.

    Authors: Yassir Sbitti, Nabil Ismaili, Youssef Bensouda, Habiba Kadiri, Mohammed Ichou and Hassan Errihani
    Citation: Journal of Hematology & Oncology 2010 3:23
    Content type: Short report Published on:

  42. With conventional radiation technique alone, it is difficult to deliver radical treatment (≥ 60 Gy) to gliomas that are close to critical structures without incurring the risk of late radiation induced complic...

    Authors: Eric Oermann, Brian T Collins, Kelly T Erickson, Xia Yu, Sue Lei, Simeng Suy, Heather N Hanscom, Joy Kim, Hyeon U Park, Andrew Eldabh, Christopher Kalhorn, Kevin McGrail, Deepa Subramaniam, Walter C Jean and Sean P Collins
    Citation: Journal of Hematology & Oncology 2010 3:22
    Content type: Research Published on:

  43. There has been little literature about leukemia epidemiology in Nanjing in recent years. We aimed to explore the incidence rate, gender and age distribution of leukemia in Nanjing using the leukemia database o...

    Authors: Bao-An Chen, Zhi-Hu Huang, Xiao-Ping Zhang, Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang, Xiao-Jing Yu, Hui Ye…
    Citation: Journal of Hematology & Oncology 2010 3:21
    Content type: Letter to the Editor Published on:

  44. A 24-year-old female patient was diagnosed with classic Hodgkin's lymphoma in clinical stage II, and combination chemotherapy followed by radiotherapy was initiated. During the following 5 years, the disease p...

    Authors: Inga Mandac and Slobodanka Ostojic Kolonic
    Citation: Journal of Hematology & Oncology 2010 3:20
    Content type: Letter to the Editor Published on:

  46. We have reviewed the pivotal presentations in non-small cell lung cancer (NSCLC) from the 2009 annual meeting of the American Society of Clinical Oncology. We have discussed the scientific data, the impact on ...

    Authors: Hamid R Mirshahidi and Chung T Hsueh
    Citation: Journal of Hematology & Oncology 2010 3:18
    Content type: Review Published on:

  48. Treatment options for patients with lower risk non-del(5q) myelodysplastic syndromes (MDS) who fail erythroid stimulating agents are restricted to one of the hypomethylating drugs with an expected response rat...

    Authors: Fahd Quddus, Jessica Clima, Helen Seedham, Ghulam Sajjad, Naomi Galili and Azra Raza
    Citation: Journal of Hematology & Oncology 2010 3:16
    Content type: Case report Published on:

  49. CD7 is a negative prognostic marker in myeloid malignancies. In acute myeloid leukemia (AML), an inverse correlation exists between expression of wild-type CEBPA and CD7. Aim of this study was to find out whether...

    Authors: Sonja Röhrs, Michaela Scherr, Julia Romani, Margarete Zaborski, Hans G Drexler and Hilmar Quentmeier
    Citation: Journal of Hematology & Oncology 2010 3:15
    Content type: Research Published on:

  50. The development of Philadelphia chromosome (Ph) negative acute leukemia/myelodysplastic syndrome (MDS) in patients with Ph-positive chronic myeloid leukemia (CML) is very rare. The features of restrictive usag...

    Authors: Liang Wang, Kanger Zhu, Xianfeng Zha, Shaohua Chen, Lijian Yang, Si Chen and Yangqiu Li
    Citation: Journal of Hematology & Oncology 2010 3:14
    Content type: Research Published on:
JHO logo
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    28.5 - 2-year Impact Factor
    23.1 - 5-year Impact Factor
    4.045 - SNIP (Source Normalized Impact per Paper)
    6.046 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    59 days submission to accept (Median)

    2023 Usage 
    3,173,795 downloads
    2,671 Altmetric mentions

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us